One of GLP-1 primary effects is slowing gastric emptying, the rate at which food moves from the stomach into the small intestine
Many adults develop them after age 30
Diabetes, Obesity & Metabolism, 20 ,
This is standard for all compounded semaglutide providers , not unique to WeightCare
A comprehensive listing of the hundreds of remaining significant differences seen in the semaglutide-treated ischemic myocardium lays outside the scope of this manuscript, and raw data is available upon request to the author
Nausea, Vomiting, or Loss of Appetite: These symptoms, when experienced alongside constipation, may suggest that food is not moving through your digestive system properly and warrant immediate medical evaluation